ID

34431

Descripción

Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02486354

Link

https://clinicaltrials.gov/show/NCT02486354

Palabras clave

  1. 17/1/19 17/1/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-small Cell Lung Cancer NCT02486354

Eligibility Non-small Cell Lung Cancer NCT02486354

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed locally advanced/metastatic (stage iiib/stage iv, using the american joint committee on cancer [ajcc] 6th edition of tumor-node-metastasis [tnm] staging system) nsclc patients
Descripción

ID.1

Tipo de datos

boolean

progressed after at least one platinum-based chemotherapy regimen at entry
Descripción

ID.2

Tipo de datos

boolean

eastern cooperative oncology group (ecog) performance status (ps) 0-2
Descripción

ID.3

Tipo de datos

boolean

at least one measurable lesion by response evaluation criteria in solid tumors version 1.0
Descripción

ID.4

Tipo de datos

boolean

adequate hematologic and biochemical values
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with symptomatic brain metastases
Descripción

ID.6

Tipo de datos

boolean

malignant tumor within the previous five years
Descripción

ID.7

Tipo de datos

boolean

severe infection; congestive heart failure
Descripción

ID.8

Tipo de datos

boolean

previous treatment with drugs targeting egfr
Descripción

ID.9

Tipo de datos

boolean

history of interstitial lung disease
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Non-small Cell Lung Cancer NCT02486354

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically or cytologically confirmed locally advanced/metastatic (stage iiib/stage iv, using the american joint committee on cancer [ajcc] 6th edition of tumor-node-metastasis [tnm] staging system) nsclc patients
boolean
ID.2
Item
progressed after at least one platinum-based chemotherapy regimen at entry
boolean
ID.3
Item
eastern cooperative oncology group (ecog) performance status (ps) 0-2
boolean
ID.4
Item
at least one measurable lesion by response evaluation criteria in solid tumors version 1.0
boolean
ID.5
Item
adequate hematologic and biochemical values
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
patients with symptomatic brain metastases
boolean
ID.7
Item
malignant tumor within the previous five years
boolean
ID.8
Item
severe infection; congestive heart failure
boolean
ID.9
Item
previous treatment with drugs targeting egfr
boolean
ID.10
Item
history of interstitial lung disease
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial